Related Experiment Video
Updated: Jun 4, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells
1Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abstract:
Head and neck squamous cell carcinoma (HNSCC) cells exposed to cisplatin (CIS) displayed a dramatic ATM-dependent phosphorylation of ΔNp63α that leads to the transcriptional regulation of downstream mRNAs. Here, we report that phospho (p)-ΔNp63α transcriptionally deregulates miRNA expression after CIS treatment. Several p-ΔNp63α-dependent microRNA species (miRNAs) were deregulated in HNSCC cells upon CIS exposure, including miR-181a, miR-519a, and miR-374a (downregulated) and miR-630 (upregulated). Deregulation of miRNA expression led to subsequent modulation of mRNA expression of several targets (TP53-S46, HIPK2, ATM, CDKN1A and 1B, CASP3, PARP1 and 2, DDIT1 and 4, BCL2 and BCL2L2, TP73, YES1, and YAP1) that are involved in the apoptotic process. Our data support the notion that miRNAs are critical downstream targets of p-ΔNp63α and mediate key pathways implicated in the response of cancer cells to chemotherapeutic drugs.
Insights
Chemotherapy drug cisplatin alters microRNA expression in head and neck cancer cells. This change, mediated by phospho-ΔNp63α, affects apoptosis pathways and drug response.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Head and neck squamous cell carcinoma (HNSCC) is a prevalent cancer.
- Cisplatin (CIS) is a common chemotherapeutic agent used in HNSCC treatment.
- The role of ΔNp63α and its phosphorylation in HNSCC response to CIS is under investigation.
Purpose of the Study:
- To investigate the role of phospho-ΔNp63α in regulating microRNA (miRNA) expression following cisplatin treatment in HNSCC.
- To identify specific miRNAs deregulated by p-ΔNp63α and their downstream effects on apoptosis-related genes.
Main Methods:
- Exposure of HNSCC cells to cisplatin (CIS).
- Analysis of ATM-dependent phosphorylation of ΔNp63α.
- Quantification of miRNA and mRNA expression levels.
- Bioinformatic analysis to identify target genes.
Main Results:
- CIS treatment induced ATM-dependent phosphorylation of ΔNp63α in HNSCC cells.
- Phospho-ΔNp63α transcriptionally deregulated several miRNAs, including downregulation of miR-181a, miR-519a, miR-374a, and upregulation of miR-630.
- Deregulation of these miRNAs modulated the expression of key apoptosis-related genes (e.g., TP53, ATM, CASP3, BCL2).
Conclusions:
- MicroRNAs are critical downstream targets of p-ΔNp63α in HNSCC cells treated with cisplatin.
- p-ΔNp63α-mediated miRNA deregulation plays a significant role in the apoptotic response to chemotherapeutic drugs.
- These findings highlight a novel mechanism in cancer cell response to chemotherapy.
Related Concept Videos
Abnormal Proliferation
piRNA - Piwi-interacting RNAs
MicroRNAs
MicroRNAs
Negative Regulator Molecules
The Nucleolus
